Last edition
News about "CureVac "
CureVac Welcomes Axel Sven Malkomes as New Chief Financial Officer
Malkomes joins CureVac at a pivotal moment as the company enters a new chapter of growth and innovation, bringing over three decades of senior corporate and investment banking experience within the biotech and pharmaceutical industries.
CureVac | 05/11/2024 | By Aishwarya
CureVac Welcomes Thaminda Ramanayake as New Chief Business Officer
CureVac has announced the appointment of Thaminda Ramanayake as the new Chief Business Officer.
CureVac | 25/04/2024 | By Aishwarya | 430
CureVac announced together with its collaboration partner GSK, first preclinical data in A Rat Model, Showing That Its Second-Generation Covid-19 vaccine candidate, CV2CoV, induces high levels of antigen production as well as strong and dose-dependent immune responses in vaccinated animals
CureVac | 15/05/2021 | By Darshana | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy